Showing results (411-420 of 8,076) with videos related to

Sort By:
Pageof 808
Clinical and Experimental Rheumatology|April 7, 2016
Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of lifeGrégory Pugnet, Christian Pagnoux, Benjamin Terrier, et al.
Clinical and Experimental Rheumatology|April 7, 2016
A multidimensional 'path analysis' model of factors explaining fatigue in rheumatoid arthritisSanne A A Rongen-van Dartel, Han Repping-Wuts, Rogier Donders, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: results from the MARI studyMaria Manara, Gerolamo Bianchi, Eleonora Bruschi, et al.
Clinical and Experimental Rheumatology|April 7, 2016
To what extent is foot pain related to biomechanical changes and ultrasound-detected abnormalities in rheumatoid arthritis?María Luz González-Fernández, Lara Valor, Rosario Morales-Lozano, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) dataTae-Jong Kim, Ji-Hui Shin, Il-Hoon Sung, et al.
Clinical and Experimental Rheumatology|April 8, 2016
Validation of the Spanish version of the fibromyalgia rapid screening tool to detect fibromyalgia in primary care health centresBenigno Casanueva, Rafael Belenguer, José V Moreno-Muelas, et al.
Clinical and Experimental Rheumatology|September 1, 1989
Rheumatic manifestations of immune deficiencyS J Preston, W W Buchanan
Clinical and Experimental Rheumatology|April 19, 2016
Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockadeRoberta Gualtierotti, Francesca Ingegnoli, Samantha Griffini, et al.
Clinical and Experimental Rheumatology|April 19, 2016
Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trialJoel M Kremer, Ricardo Blanco, Anne-Marie Halland, et al.
Clinical and Experimental Rheumatology|April 19, 2016
Sleep quality in patients with primary Sjögren's syndromeRoberta Priori, Antonina Minniti, Barbara Antonazzo, et al.
Pageof 808